IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

China SXT Pharmaceuticals in (SXTC)

CUSIP: G2161P165 | Healthcare · Drug Manufacturers - Specialty & Generic | Micro Cap | 4 institutional holders

Quarters

Q2 2026Q1 2026
CompareDetailedHistoricalFundsOptionsShort Interest13D/13GPeersTargetingTrading SummaryProfile

Institutional Holders — Q2 2026

Royal Bank of Canada13
0.0% of portfolio›$0
Caitong International Asset Management Co., Ltd2
0.0% of portfolio›$4
UBS Group AG1
0.0% of portfolio›$2
StyleTurnoverLocationFiled
Royal Bank of Canada
13$00.0%CoreLowToronto, Australia2026-08-14
Caitong International Asset Management Co., Ltd
2$40.0%GrowthVery HighHong Kong, South Korea2026-08-05
UBS Group AG
1$20.0%CoreMediumZurich, Switzerland2026-08-13